Series A funding round for Interius BioTherapeutics raising $76M in May 2021
Series A funding round for Interius BioTherapeutics raising $76M in May 2021
| Investor | Firm Type |
|---|
| Partner |
|---|
FairmountLEAD | Venture Capital | — |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Non Profit | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| University Fund | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$88M
Top Valuation
-
Interius BioTherapeutics raised $76M in a Series A round.
The round was announced on 05/01/21.
The round was led by Cormorant Asset Management, Tomas Kiselak.